Humacyte Inc (HUMA NASDAQ) stock market data APIs
$1.3103
0.15(11.4%)
as of November 6, 2025
Try our APIs with
free plan!
Humacyte Inc Financial Data Overview
Price chart is built with
Anychart
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Prev. Close
1.3103
Open
1.4592
High
1.4592
Low
1.2678
52 wk Range
1.15-6.77
Market Cap
245 M
Shares Outstanding
187 M
Revenue
818 K
EPS
0
Beta
1.881
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Humacyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Humacyte Inc data using free add-ons & libraries
Get Humacyte Inc Fundamental Data
Humacyte Inc Fundamental data includes:
- Net Revenue: 818 K
- EBITDA: -103 920 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-07
- EPS/Forecast: -0.1591
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Humacyte Inc News
New
Humacyte, Inc. (HUMA) Declines More Than Market: Some Information for Investors
Humacyte, Inc. (HUMA) ended the recent trading session at $1.31, demonstrating a -10% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 1.12%. Meanwhile, the ...
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at comme...
Humacyte, Inc. (HUMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest close session, Humacyte, Inc. (HUMA) was down 4.14% at $1.62. This move lagged the S&P 500's daily loss of 0.99%. Meanwhile, the Dow experienced a drop of 0.23%, and the technology-domin...
Humacyte, Inc. (HUMA) Surpasses Market Returns: Some Facts Worth Knowing
In the latest close session, Humacyte, Inc. (HUMA) was up +1.18% at $1.71. This move outpaced the S&P 500's daily gain of 0.79%. Elsewhere, the Dow gained 1.01%, while the tech-heavy Nasdaq added 1.15...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
